Clinical Trials on Solid Carcinoma in Taiwan

Total 1363 results

Chang Gung Memorial Hospital

Recruiting

Dose Escalation and Dose Expansion Study of GAS in Subjects With Metastatic Pancreatic Adenocarcinoma (GAS)

Metastatic Pancreatic Adenocarcinoma

Taiwan
AbbVie

Active, not recruiting

Study of Intravenous (IV) ABBV-637 Alone or in Combination With IV Docetaxel/Osimertinib to Assess Adverse Events and Change in Disease Activity in Adult Participants With Relapsed/Refractory (R/R) Solid Tumors

Advanced Solid Tumors Cancer | Non Small Cell Lung Cancer (NSCLC)

United States, Australia, France, Israel, Japan, Korea, Republic of, Spain, Taiwan
Far Eastern Memorial Hospital

Unknown

A Study of Weekly Docetaxel Plus Cisplatin Followed by Gemcitabine vs. Gemcitabine Plus Cisplatin Followed by Weekly Docetaxel in the Treatment of Advanced Non-Small-Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

Taiwan
Hoffmann-La Roche

Completed

A Study of Tarceva (Erlotinib) as First Line Therapy in Participants With Non-Small Cell Lung Cancer Harbouring Epidermal Growth Factor Receptor (EGFR) Mutations

Non-Squamous Non-Small Cell Lung Cancer

Hong Kong, Korea, Republic of, Taiwan, Thailand
vghtpe user

Terminated

A Prospective Study on Sunitinib as First Line Therapy for Advanced/Metastatic Renal Cell Carcinoma in Asian Population

Renal Cell Carcinoma

Taiwan
AbbVie (prior sponsor, Abbott)
Genentech, Inc.

Completed

Phase 2 Study of ABT-869 in Advanced Hepatocellular Carcinoma (HCC)

Advanced Hepatocellular Carcinoma

United States, Canada, Singapore, Taiwan
Taichung Veterans General Hospital

Completed

Massive Nasal Bleeding in Patients With NPC Received Curative RT

Nasopharyngeal Carcinoma Patients Treated With Curative Radiotherapy

Taiwan
Novartis Pharmaceuticals

Completed

Patupilone Activity in Advanced/Metastatic Hepatocellular Carcinoma

Hepatocellular Carcinoma

United States, Hong Kong, Taiwan, Korea, Republic of
Ludwig Institute for Cancer Research
Memorial Sloan Kettering Cancer Center; National Taiwan University Hospital; Duke... and other collaborators

Terminated

Study of ADI-PEG 20 in Patients With Relapsed Sensitive or Refractory Small Cell Lung Cancer

Small Cell Lung Cancer

United States, Taiwan, Germany, Belgium, United Kingdom
National Taiwan University Hospital

Unknown

The Analyses of Treatment Efficacy and Cost-effectiveness in Early-staged Ovarian Cancer Patients

Ovarian Cancer

Taiwan
National Taiwan University Hospital

Unknown

Epidemiology of Ovarian Cancer in Taiwan

Ovarian Cancer

Taiwan
National Taiwan University Hospital

Unknown

Characterization of Ovarian Cancer Stem Cell

Ovarian Cancer

Taiwan
National Taiwan University Hospital

Unknown

Screening and Identification of Ovarian Cancers

Ovarian Cancer

Taiwan
National Taiwan University Hospital

Unknown

The Assessment of Mesothelin Antigen Specific Immunologic Assays in Ovarian Cancer Patients

Ovarian Cancer

Taiwan
National Taiwan University Hospital

Unknown

Mesothelin as a New Tumor Marker for Ovarian Cancer

Ovarian Cancer

Taiwan
Impact Therapeutics, Inc.
Covance

Recruiting

The Safety and Pharmacokinetics Preliminary Efficacy of IMP7068 in Patients With Advanced Solid Tumors (WEE1)

Advanced Solid Tumors

United States, Taiwan, China
National Health Research Institutes, Taiwan
National Taiwan University Hospital; National Cheng-Kung University Hospital

Terminated

A Phase II Trial of LDK378 in ROS1 and /or ALK Over-expressed Advanced Intrahepatic or Hilar Cholangiocarcinoma

Cholangiocarcinoma

Taiwan
Taipei Veterans General Hospital, Taiwan

Completed

Concurrent Chemoradiotherapy (CCRT) With Paclitaxel Plus Cisplatin in LA Non-small-cell Lung Cancer (NSCLC)

Non-small-cell Lung Cancer

Taiwan
Novartis Pharmaceuticals

Completed

Phase Ib/II Study of INC280 + PDR001 or PDR001 Single Agent in Advanced HCC

Advanced Hepatocellular Carcinoma

Taiwan, Canada, Italy, Korea, Republic of, Hong Kong, Germany, China, France
National Cancer Institute (NCI)

Terminated

Defining the Clinical Utility of EBV Antibody Screening to Identify Individuals Susceptible to Nasopharyngeal Carcinoma (NPC) Within High-Risk, Multiplex NPC Families

Nasopharyngeal Neoplasms

China
Taichung Veterans General Hospital

Completed

Plasma EBV DNA Monitoring in Post-treatment NPC Patients

Nasopharyngeal Carcinoma | Radiotherapy | EBV | NPC

Taiwan
National Taiwan University Hospital
National Health Research Institutes, Taiwan

Unknown

Molecular Mechanism of Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Taiwan
Antengene Biologics Limited

Recruiting

A Study of ATG-022 in Patients With Advanced/Metastatic Solid Tumors (CLINCH)

Advanced/Metastatic Solid Tumors

China, Australia
Eli Lilly and Company
AstraZeneca

Completed

A Study of Ramucirumab (LY3009806) or Necitumumab (LY3012211) Plus Osimertinib in Participants With Lung Cancer

Non-small Cell Lung Cancer

Spain, United States, Korea, Republic of, Taiwan, France
Beijing Konruns Pharmaceutical Co., Ltd.

Recruiting

A Study of KC1036 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

China
National Taiwan University Hospital

Unknown

Treatment Result of KTP Laser Nasopharyngectomy in Recurrent NPC Patients

Nasopharyngeal Carcinoma | Recurrent

Taiwan
National Taiwan University Hospital
National Health Research Institutes, Taiwan

Recruiting

Harmonics-based in Vivo Optical Virtual Biopsy

Healthy Participants With Different Skin Types and Different Ages | Diseased Participants With Different Skin Types and Different Ages | Participants Suffered From Diabetes With Different Skin Types and Different Ages

Taiwan
National Health Research Institutes, Taiwan

Completed

A Multi-center Survey of HPV in Cervical Intraepithelial Neoplasia (CIN) With Longitudinal Follow-up of LSIL Cases

Cervical Cancer | Human Papillomavirus | Low-grade Squamous Intraepithelial Lesion,

Taiwan
Tzu Chi University

Unknown

Baduanjin Exercise on Meridian Energy, Lung Function and Heart Rate Variability in Patients Undergoing Lung Operative.

Lung Cancer Non Small Cell

Taiwan
Sichuan Baili Pharmaceutical Co., Ltd.

Recruiting

SI-B001 Combined With Irinotecan in the Treatment of Recurrent Metastatic Esophageal Squamous Cell Carcinoma.

Esophageal Squamous Cell Carcinomas

China
Taipei Veterans General Hospital, Taiwan

Unknown

A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol (S-HCC)

Hepatocellular Carcinoma | Gastroesophageal Varices Hemorrhage

Taiwan
Pfizer

Completed

A Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer Which Could Not Be Controlled

Non-Small Cell Lung Carcinoma

Taiwan
Mackay Memorial Hospital
OBI Pharma, Inc

Unknown

Trial of Active Immunotherapy With Globo H-KLH (OPT-822/821) in Women Who Have Non-Progressive Ovarian Cancer

Ovarian Cancer

Taiwan
National Taiwan University Hospital

Unknown

The Role of Regulatory T Cell in Ovarian Cancer: Focus on Relationship Between Clinical Prognosis and Regulatory T Cell Expression (Tregs)

Ovarian Cancer

Taiwan
National Taiwan University Hospital

Unknown

Establishing the Incidences of BRCA1 and BRCA2 Mutation by Combining DHPLC and Direct Sequencing in Ovarian Cancer

Ovarian Cancer

Taiwan
Novartis Pharmaceuticals

Terminated

Safety and Efficacy of RAD001 + TACE in Localized Unresectable HCC (TRACER)

Hepatocellular Carcinoma

Hong Kong, Taiwan, Thailand
Sanofi

Terminated

A First-in-human Study of the Safety, Pharmacokinetics, Pharmacodynamics and Anti-tumor Activity of SAR439459 Monotherapy and Combination of SAR439459 and Cemiplimab in Patients With Advanced Solid Tumors

Malignant Solid Tumor

France, Spain, Australia, Belgium, Italy, United Kingdom, Taiwan, Estonia, Netherlands, Korea, Republic of, United States, Canada, Germany
Chang Gung Memorial Hospital

Completed

Tumor Associated Macrophage in Advanced Non-small Cell Lung Cancer

Advanced Nonsmall Cell Lung Cancer

Taiwan
Taipei Veterans General Hospital, Taiwan

Completed

Pemetrexed Followed by Docetaxel or in Reverse Sequence

Non-small-cell Lung Cancer

Taiwan
Eli Lilly and Company

Completed

Chemotherapy for Patients With Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer

Taiwan
National Taiwan University Hospital

Unknown

EGCG Modulate the Cytotoxic Effects of Chemotherapeutic Agents in Human Urothelial Carcinoma Cells

Urothelial Carcinoma

Taiwan
Astellas Pharma Global Development, Inc.
Merck Sharp & Dohme LLC

Completed

A Multiple-dose Study of ASP8374, an Immune Checkpoint Inhibitor, as a Single Agent and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

Advanced Solid Tumors

United States, Korea, Republic of, Taiwan, Portugal, Spain, United Kingdom, Italy, Canada, Japan
Genmab
BioNTech SE

Recruiting

GEN1042 Safety Trial and Anti-tumor Activity in Subjects With Malignant Solid Tumors

Melanoma | Malignant Solid Tumor | Non Small Cell Lung Cancer (NSCLC) | Pancreatic Ductal Adenocarcinoma (PDAC) | Head and Neck Squamous Cell Carcinoma (HNSCC) | Colorectal Cancer (CRC)

United States, Taiwan, Spain, Israel, Korea, Republic of, France, Italy, Denmark, Germany, United Kingdom, Georgia, Moldova, Republic of
Taipei Veterans General Hospital, Taiwan

Completed

UFUR (Tegafur/Uracil) Plus Iressa in Non-small-cell Lung Cancer

Non-Small-Cell Lung Cancer

Taiwan
National Taiwan University Hospital

Unknown

Crizotinib Efficacy In Non-Small Cell Lung Cancer Patients With Anaplastic Lymphoma Kinase Translocation

Non-small Cell Lung Cancer(NSCLC)

Taiwan
National Taiwan University Hospital

Unknown

Genotyping of Non-small Cell Lung Cancer

Non-small Cell Lung Cancer | Gene Abnormality

Taiwan
Oncolys BioPharma Inc
Medigen Biotechnology Corporation

Unknown

Phase I Study to Evaluate the Safety and Efficacy of Telomelysin (OBP-301) in Patients With Hepatocellular Carcinoma

Carcinoma, Hepatocellular

Taiwan, Korea, Republic of
Precision Biotech Taiwan Corp.
Tri-Service General Hospital

Recruiting

Allogeneic PB103 (NK Cells) Therapy in Non-small Cell Lung Cancer (NSCLC) Patients

Non-small Cell Lung Cancer

Taiwan
National Taiwan University Hospital

Unknown

Bevacizumab and Erlotinib in Lung Cancer With Brain Metastases, a Phase II Trial (BRILLIANT)

Carcinoma, Non-Small-Cell Lung | Brain Neoplasms

Taiwan
Chang Gung Memorial Hospital

Unknown

Effect of Astragalus-based Formula: Qingshu-Yiqi-Tang on Modulating Immune Alterations in Lung Cancer Patients (QSYQT)

Carcinoma, Non-Small-Cell Lung

Taiwan

Clinical Trials on Solid Carcinoma in Taiwan

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Nigeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations